Clinical Trial Update: TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating total marrow and lymphoid irradiation (TMLI) with chemotherapy for high-risk myelodysplastic syndromes and acute myeloid leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Total Marrow and Lymphoid Irradiation (TMLI)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Myelodysplastic Syndromes, Myeloid Leukemia, Acute | Phase 2 | Status: NOT_YET_RECRUITING